Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aardvark Therapeutics, Inc. (AARD) vs. Competitors

142 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AARDAardvark Therapeutics, Inc.$1.33$29.11M-0.40-87.75%Moderate SellUnlock the AARD analyst price target with TipRanks PremiumAARDUnlock the AARD top-analyst price target with TipRanks Premium
CUECue Biopharma$16.12$117.10M-0.60-13.28%Moderate BuyUnlock the CUE analyst price target with TipRanks PremiumAARD vs CUEUnlock the CUE top-analyst price target with TipRanks Premium
EQEquillium$1.29$106.20M-7.3253.57%Strong BuyUnlock the EQ analyst price target with TipRanks PremiumAARD vs EQUnlock the EQ top-analyst price target with TipRanks Premium
ADCTADC Therapeutics$1.34$188.49M-2.56-66.91%HoldUnlock the ADCT analyst price target with TipRanks PremiumAARD vs ADCTUnlock the ADCT top-analyst price target with TipRanks Premium
NKTXNkarta$1.19$85.33M-0.69-36.70%Strong BuyUnlock the NKTX analyst price target with TipRanks PremiumAARD vs NKTXUnlock the NKTX top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%200%250%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AARDAardvark Therapeutics, Inc.1.33-9.03-87.16%
CUECue Biopharma16.12-1.10-6.39%
EQEquillium1.290.2422.86%
ADCTADC Therapeutics1.34-2.63-66.25%
NKTXNkarta1.19-0.62-34.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts